Tempest Therapeutics (TPST) EBIT Growth (5y) (2017 - 2026)
Powered by 
Analysis
Tempest Therapeutics (TPST) EBIT Growth (5y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | Tempest Therapeutics | 3.35 Mn | 2.55 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.00% |
| Dec 31, 2025 | 34.68% |
| Sep 30, 2025 | -21.63% |
| Jun 30, 2025 | -8.75% |
| Mar 31, 2025 | 2.06% |
| Dec 31, 2024 | -1.64% |
| Sep 30, 2024 | 2.13% |
| Jun 30, 2024 | 1.16% |
| Mar 31, 2024 | 5.64% |
| Dec 31, 2023 | 4.97% |
| Sep 30, 2023 | 3.32% |
| Jun 30, 2023 | -8.42% |
| Mar 31, 2023 | -11.56% |
| Dec 31, 2022 | 26.76% |
| Sep 30, 2022 | 1.39% |
| Jun 30, 2022 | 13.32% |
| Mar 31, 2022 | 10.97% |
| Dec 31, 2021 | 19.98% |
| Sep 30, 2021 | 16.42% |
| Jun 30, 2021 | 17.95% |